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Costimulatory signals are critical to T cell activation,
but how their effects are mediated remains incom-
pletely characterized. Here, we demonstrate that lo-
cally produced C5a and C3a anaphylatoxins interact-
ing with their G protein-coupled receptors (GPCRs),
C5aR and C3aR, on APCs and T cells both upstream
and downstream of CD28 and CD40L signaling are
integrally involved in T cell proliferation and differenti-
ation.Disabling these interactions reducedMHCclass
II and costimulatory-molecule expression and dra-
matically diminished T cell responses. Importantly,
impaired T cell activation by Cd80/Cd86/ and
Cd40/ APCs was reconstituted by added C5a or
C3a. C5aR and C3aR mediated their effects via PI-3
kinase-g-dependent AKT phosphorylation, providing
a link between GPCR signaling, CD28 costimulation,
andTcell survival. These localparacrineandautocrine
interactions thus operate constitutively in naive T cells
tomaintainviability, and their amplificationbycognate
APC partners thus is critical to T cell costimulation.
INTRODUCTION
Adaptive immune responses must not only be strong enough for
host defense but must also avoid autoreactivity and maintain
homeostasis. Consequently, antigen-induced expansion and
differentiation of T cells must be tightly controlled. Important
in this control is the requirement for costimulation. Initially, this
involves the dependence of T cell proliferation on the engage-
ment of antigen-presenting cell (APC) B7 and CD40 by T cell
CD28 and CD40 ligand (CD40L) (‘‘Signal 2’’). Subsequently, it in-
volves the dependence of T cell differentiation on the elaboration
by APC partners of IL-12 and IL-23 and other cytokines (‘‘Signal
3’’). How these receptor-counterreceptor engagements mediate
these two processes remains incompletely characterized.
The complement system is thought to be integral to the innate
immune system and function in adaptive immunity only in hu-moral immune responses (Janeway et al., 2005). Because of
this, data implicating complement as impacting adaptive T cell
responses have been attributed to ‘‘crosstalk’’ effects of com-
plement activation fragments deriving from serum complement
acting on APCs or T cells exogenously. Among these data are
findings that antiviral T cell responses are attenuated in C3/
mice (Kopf et al., 2002) and T cell-mediated renal injury is
depressed in C5a receptor (C5ar1)/ MRL/lpr mice (Wenderfer
et al., 2005).
In recent studies (Heeger et al., 2005), we found that T cell
responses are markedly augmented in mice targeted in the
homolog (Daf1) (Lin et al., 2001) of the gene that encodes human
decay-accelerating factor (DAF or CD55), a surface C3 and
C5 convertase inhibitor that prevents complement activation
on self-cell surfaces (Medof et al., 1984). To understand the basis
for this augmentation, we studied wild-type (WT) cells and found
that when WT T cells interact with WT APCs bearing peptide
specific for their T cell receptor (TCR), both cognate partners lo-
cally synthesize the alternative-pathway components C3, factor
B (fB), and factor D (fD). These three components spontaneously
activate on foreign targets but not on self cells that express
C3 and C5 convertase inhibitors. Although we had no evidence
indicating that the locally generated components, in fact, acti-
vate, we found that concomitant with the local C3, fB and fD syn-
thesis, WT APCs downregulate surface DAF expression lowering
local C3 and C5 convertase inhibitory activity. We additionally
found that the augmented T cell responses did not occur when
Cd55/Cfd/ double-knockout APCs were used and that
administration of anti-C5 mAb inhibited the generation of IFNg-
producing cells in vivo, whereas addition of C5a augmented it
in vitro. These findings raised the possibility that in WT cells,
complement activation products locally produced at the APC-T
cell interface might indeed be involved in the T cell activation
process.
In view of this, we initiated studies to determine whether C5a
and/or another activation fragment i.e., C3a, generated from
complement endogenously produced by cognate APC-T cell
partners, participate(s) in T cell differentiation into IFNg+ effector
cells. C5a and C3a are10 kDa anaphylatoxins able to ligate the
C5a receptor (C5aR) and the C3a receptor (C3aR) that are G pro-
tein-coupled receptors (GPCRs) generally expressed on APCs
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Local C5a+C3a Support T Cell Activation and SurvivalFigure 1. APC-T Cell Partners Upregulate
Complement mRNAs and the RNAs Pro-
duce Proteins
(A) OT-II T cells were incubated for 1 hr with WT
DCs ± 0.1 mM OVA323–339, flow separated (with
anti-CD3 and anti-CD11c), and complement
mRNA expression in each partner was measured
by qPCR.
(B) OT-II cells and DCs were flow separated at
increasing times, and complement IL-2, IFN-g,
IL-12, and IL-23 gene expression was measured
by qPCR.
(C) The left side shows representative (rep) histo-
grams (four exps; linear scales) depicting C5aR
or C3aR on OT-II cells and DCs before (no OVA)
and after 1 hr interaction with OVA. The right side
shows that after 24 hr of interaction of DCs with
OT-II cells ± OVA, flow-separated cells were
cultured for 4 hr, and supernatants were blotted
for C3a and C5a; stds = 2 ng.
(D) Kinetics of C5aR, C3aR, and DAF protein ex-
pression on OT-II T cells and DCs during interac-
tion with ova. Fold increase is relative to no OVA
cultures. DAF levels on the DCs were low at all
time points.
(E) After interaction of OT-II cells with DCs ± ova
for 18 hr with 4 mg/ml anti-B7.1 and anti-B7.2
mAbs or control IgG, mRNAs in flow-separated
cells were assayed for C3, C3aR, C5aR, and
IFNg gene expression by qPCR. In parallel cul-
tures, IFNg was assessed by ELISPOT. No com-
plement or cytokine upregulation occurred without
T cells. Data are normalized to no OVA. Each ex-
periment is representative of two to four replicate
studies. *p < 0.05 versus controls. All error bars
are ± SD.and reported under some conditions to be detectable on T cells
(Soruri et al., 2003). We performed studies with primary APCs
and T cells by using two independent approaches, genetic defi-
ciency and pharmacological blockade, to assess whether and, if
so, how the local complement production relates to physiologi-
cal T cell responses. After finding that these GPCR engagements
indeed are integrally involved in the T cell activation process
physiologically, we investigated the mechanism and unexpect-
edly found that their signaling not only functions integrally in
costimulation but also operates constitutively in naive T cells to
sustain their viability.
RESULTS
Cognate APC-T Cell Partners Locally Generate C5a
and C3a and Upregulate C5aR and C3aR
Our previous studies (Heeger et al., 2005) revealed that APC-T
cell cognate partners locally synthesize C3, fB, and fD,
that added C5a influences the strength of the induced T cell
response, and that DAF, which inhibits the generation of C3a
as well as C5a, is downregulated on APCs. To establish whether
these findings are relevant to T cell activation physiologically and
provide mechanistic insight, we tested whether APCs and T cells
additionally synthesize C5 as well as C5aR and C3aR that could
result in local C5a-C5aR and/or C3a-C3aR engagements.426 Immunity 28, 425–435, March 2008 ª2008 Elsevier Inc.Initially, we incubated OT-II TCR transgenic T cells with
OVA323–339 peptide plus bone-marrow-derived dendritic cells
(DCs) as APCs. At various time points, we flow separated the
APCs and T cells, isolated their RNA, and assayed comple-
ment-gene-expression patterns in the two partners by qPCR.
These assays showed that in addition to upregulating C3, fB,
and fD, both the APCs and T cells indeed upregulated mRNAs
for C5 as well as C5aR and C3aR (Figure 1A). Notably, although
both partners produced complement, on the basis of a quantita-
tive analysis of per-cell copy number with an internal standard
(data not shown), C3 mRNA was produced in1000-fold excess
by the APCs compared to the T cells both at rest and after
activation. The analyses also showed that during cognate inter-
actions, T cells as well as the APCs concurrently downregulated
Daf1 mRNA (Figures 1A and 1B), thereby further lowering re-
straint on local C3, fB, fD, and C5 activation.
Kinetic analyses (Figure 1B) revealed that the complement up-
regulation in T cells preceded the well-established, activation-
induced upregulation of CD40L mRNA expression (Diehl et al.,
2000), and that both preceded IL-2 mRNA expression. In the
DCs, C3 mRNA upregulation occurred much earlier than upregu-
lation of IL-1, IL-12p35, and IL-23p19 mRNAs known to influence
T cell differentiation. As expected, the upregulation of IL-12p35
mRNA by the DCs (2-fold at 2 hr) preceded the upregulation of
IFNg mRNA in the OT-II cells (2-fold >3 hr).
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Local C5a+C3a Support T Cell Activation and SurvivalFigure 2. Disabling C3aR and C5aR
Prevents T Cell Immunity In Vitro
(A) OT-II T cells were incubated for 48 hr with WT
DCs and OVA323–339 ± 10 ng/ml C5aR-A and 10
ng/ml C3aR-A and either flow separated and as-
sayed for mRNA expression by qPCR (left and
middle) or assayed for IFNg+ cells by ELISPOT
(right; dots represent overlapping replicates, n =
5 per group).
(B) OT-II T cells were incubated for 48 hr at 37C
with WT, C3ar1/, C5ar1/, C5ar1/C3ar1/,
or C3/Hc/ DCs + OVA323–339 and assayed
for IFNg+ cells by ELISPOT.
(C) Purified WT, C3ar1/, C5ar1/, or C5ar1/
C3ar1/ T cells (>96% CD3+) were stimulated
with 1 mg/ml anti-CD3 + 1 mg/ml anti-CD28 for 3
days and assayed for IFNg+ cells (n = 5 each
group; some dots overlap.
(D) OT-II T cells were incubated for 48 hr at 37C
with WT or C3ar1/C5ar1/ DCs in the presence
of 10 ng/ml C5aR-A and C3aR-A or 10 mg/ml anti-
C5a+C3a mAbs, after which IFN-g producing cells
were assayed by ELISPOT. Each experiment was
repeated at least twice with comparable results.
*p < 0.05. All error bars are ± SD.To determine whether the changes in mRNA translated into
differences in protein production, we performed flow-cytometric
analyses (Figures 1C and 1D). These assays confirmed upregu-
lated expression of C5aR and C3aR levels on both the T cells and
APCs. The upregulated surface C5aR and C3aR on both part-
ners persisted in the presence but not absence of OVA peptide
(Figure 1D), documenting antigen dependence. Immunoblot-
tings performed on the serum-free culture supernatants showed
the 10 kB C5a and C3a ligands for C5aR and C3aR (Figure 1C,
right), indicating that the locally produced components under-
went spontaneous alternative-pathway activation. The genera-
tion of C5a and C3a (which signal at 1013 M) and augmentation
of C5aR+C3aR on the cell surfaces continued over the ensuing 3
hr and thereafter in the APC-peptide-T cell mixture (Figure 1D).
Concurrently, surface Daf protein expression progressively de-
clined on the T cells as well as on the APCs and was well below
baseline at 3 hr. Thus, interacting APC and T cell partners both
generate C5a and C3a and upregulate C5aR and C3aR.
APC-T Cell Complement Component
and Receptor Inductions Are Dependent
on CD28-B7 and CD40-40L Couplings
To address mechanisms underlying the observed APC-T cell
complement component and receptor upregulations, we next
tested the impact of costimulation on these processes. Upon ad-
dition of blocking B71/2 mAbs, T cell differentiation and cytokine
production was diminished (Figure 1E), APC IL-12 upregulation
was prevented, C3, C3aR, and C5aR gene expression on both
partners was abrogated, C5aR and C3aR surface upregulation
did not occur, and substantially lower amounts C3a and C5a
were detected in culture supernatants (not shown). Similarly,
after the addition of the blocking anti-CD40L mAb MR-1 but
not a control IgG (Figure S1A available online), IFNg production
as well as complement-component and receptor-gene and pro-
tein upregulation by the OT-II T cells was prevented. Notably, the
abrogation of complement upregulation by the loss of either B7-CD28 or CD40-CD154 interactions was 70%, but if the two
costimulatory pairs were blocked simultaneously, the comple-
ment-gene expression was suppressed below control values
(Figure S1B). Similar results were obtained with an independent
Marilyn TCR transgenic T cell system specific for HYDby plus
I-Ab (not shown).
Thus, the data show that cognate T cell-APC interactions
along with costimulatory signals (delivered through CD80- and
CD86-CD28 and CD40-40L) induce the sustained local produc-
tion of C5a and C3a, downregulation of cell-surface expres-
sion of DAF, and persistent upregulation C5aR and C3aR. All
of these events occur prior to T cell proliferation and cytokine
secretion.
Disabling C5aR+C3aR Signaling Prevents
T Cell Responses In Vitro
In view of the findings that APC and T cell partners sustain local
generation of C5a+C3a together with augmenting their C5aR+
C3aR surface expression during cognate interactions, we tested
whether signaling through C5aR and/or C3aR by the locally
generated C5a and C3a ligands is involved in activation of T cells
by APCs.
To do this, we performed studies with OT-II cells, OVA323–339
peptide, and WT DCs in which we blocked C5a-C5aR+C3a-
C3aR engagements on the C5ar1+/+C3ar1+/+ OT-II T cells and
APCs by the addition of a C5aR antagonist (C5aR-A), a cyclic
peptide C5a analog that binds to C5aR and prevents C5aR
signaling (Morikis and Lambris, 2002), and a C3aR antagonist
(C3aR-A) that, like the C5aR-A, binds to but does not signal
through C3aR. Both antagonists block their target receptors
with high specificity (Figures S2A and S2B). The two antagonists
added together prevented upregulation of IFNg mRNA in the
responding T cells (Figure 2A, left), as well as production of
IL-12p35 and IL-23p19 mRNA in the DCs (Figure 2A, middle).
A similar result was obtained with anti-CD3+anti-CD28 stimula-
tion of WT T cells not shown.Immunity 28, 425–435, March 2008 ª2008 Elsevier Inc. 427
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Local C5a+C3a Support T Cell Activation and SurvivalFigure 3. The Absence of C3aR and C5aR
Prevents T Cell Immunity In Vivo
(A) WT or C5ar1/C3ar1/ mice (n = 3 per group)
were immunized with ovalbumin protein mixed in
IFA, and spleen cells on day 10 were assayed for
responses to OVA323–339 by ELISPOT. No re-
sponse occurred with control peptides or naive
mice.
(B) Analogous to the experiment in (A), animals
were injected s.c. with ovalbumin mixed in PBS,
and responses to OVA323–339 were assayed on
day 10.
(C) Syngeneic WT and C5ar1/C3ar1/ male
spleen cells were injected i.v. into WT or C5ar1/
C3ar1/ B6 females, respectively, and 10 days
later, recipient spleen cells were assayed for re-
sponses to class II-restricted Dby peptide.
(D) WT or C5ar1/C3ar1/ mice were infected
with T gondii. All C5ar1/C3ar1/ mice died by
day 12, whereas WT animals survived for >50
days. Spleen cells from C5ar1/C3ar1/ and
WT animals isolated on day 7 or 10 were stimu-
lated with 1 mg of Toxoplasma gondii antigen and
assayed for IFNg by ELISPOT (left) or for IL-12
by ELISA (right) (n = 5 per group each time; some
dots overlap). *p < 0.05 versus controls.
(E) Clinical scores in WT and C5ar1/C3ar1/
mice in which EAE was induced by immunization
s.c. with 200 mg MOG35–55 in CFA and 200 ng of
pertussis toxin. (n = 5 each group, p < 0.05).
(F) Globes from WT and C5ar1/C3ar1/ mice
15 days after inoculation of scratched corneas
with KDS strain of herpes simplex virus (n = 5
each group). All error bars are ± SD.To assess the contribution of C5aR and C3aR function on
APCs in mediating T cell reactivity, we mixed WT OT-II T cells
with DCs from WT, C5ar1/, C3ar1/, and C3ar1/C5ar1/
mice. The absence of either receptor from the APC diminished
T cell IFNg production by 30%–50% (Figure 2B). The impact of
the absence of both APC C3aR and C5aR was greater than
the absence of either receptor alone in that T cell IFNg produc-
tion was inhibited by greater than 75% (Figure 2B). A comparable
result was obtained if APCs from mice lacking C5 and C3 (Hc/
C3/) were used (Figure 2B). The response of the OT-II T cells
to C3ar1/C5ar1/ or Hc/C3/ APCs was markedly lower
than the previously reported inhibition (Peng et al., 2006) induced
by the absence of APC C3.
To address the impact of C5aR and C3aR on T cells, we used
anti-CD3+anti-CD28 stimulation (Figure 2C). Whereas this stim-
ulation induced IFNg production by WT T cells, stimulation of
C5ar1/C3ar1/ T cells yielded a markedly reduced response.
Similarly, when we employed anti-C5a and anti-C3a mAbs
together with C5ar1/C3ar1/ DCs in the DC-OVA323–339-OT-
II system to block OT-II C3aR and C5aR signaling, it had the
same effect (Figure 2D).
C3aR and C5aR Control T Cell Immunity In Vivo
To test the impact of APC-T cell C5a-C5aR+C3a-C3aR signaling
in vivo, we performed multiple complementary experiments.
After immunization of WT or C5ar1/C3ar1/ mice with oval-
bumin protein mixed in incomplete Freund’s adjuvant (IFA), we
found that recall responses by ELISPOT assay on day 10 were428 Immunity 28, 425–435, March 2008 ª2008 Elsevier Inc.reduced by 50% in C5ar1/C3ar1/ mice compared to WTs
(Figure 3A). To assess immunity in the absence of adjuvant, we
immunized mice with ovalbumin in PBS. As anticipated, the re-
sponses (Figure 3B) were lower, but again the frequency of spe-
cific IFNg-producing T cells was reduced by 80% in C5ar1/
C3ar1/ mice. With another approach, we injected male cells
into syngeneic H-2b WT or H-2b C5ar1/C3ar1/ mice.
Whereas HYDby responses to the HYDby (I-Ab-restricted deter-
minant) 2 weeks later were detected after the WT male transfers,
none were detected with the male C5ar1/C3ar1/ transfers
(Figure 3C). In another model system, 40% of CFSE-labeled
OT-II T cells underwent at least one round of proliferation after
adoptive transfer into WT mice primed 24 hr previously with
OVA323–339 in CFA, but <5% underwent at least one round of pro-
liferation in identically primed C5ar1/C3ar1/ mice (p < 0.05
versus WT, n = 2 per group, not shown). Similar results were ob-
tained in an allo model in which CFSE-labeled Balb/c T cells were
adoptively transferred to WT and Hc/C3/ mice (20% versus
<2% undergoing one or more rounds of proliferation, n = 2, not
shown). In another adoptive-transfer model, IFN-g producing
cells generated by C5ar1/C3ar1/ C57BL/6 female Mar
T cells into C5ar1/C3ar1/ male recipients were reduced by
33% of those generated by WT female Mar T cells injected into
male C57BL/6 recipients (not shown).
To evaluate the impact of C3aR and C5aR in clinically relevant
disease models, we infected WT and C5ar1/C3ar1/ mice
with T. gondii (ME49 strain), a system in which disease protection
is IL-12 and T cell dependent (Liu et al., 2006). The C5ar1/
Immunity
Local C5a+C3a Support T Cell Activation and SurvivalFigure 4. Locally Produced C5a and C3a
Interactwith C5aRandC3aR in anAutocrine
and Paracrine Fashion to Augment T Cell
Immunity
(A) OT-II T cells were incubated for 1 hr with WT
DCs and 0.1 mM OVA323–339 ± 10 ng/ml C5aR-A
and 10 ng/ml C3aR-A and either flow separated
and assayed for mRNA expression (C3, C5aR,
C3aR; left and middle) or analyzed (after 24 hr)
for C3aR and C5aR by flow cytometry (right);
C3aR and C5aR levels on peritoneal macrophages
are 14- and 13-fold higher.
(B) The left side shows that complement-gene ex-
pression was assessed in purified WT T cells after
1 hr stimulation with 1 mg/ml anti-CD3 + 1 mg/ml
anti-CD28 ± 10 ng/ml of C5aR-A and C3aR-A.
The right side shows that C3 expression was com-
pared between purified WT andC5ar1/C3ar1/
T cells stimulated with 1 mg/ml each of anti-
CD3+anti-CD28.
(C) Supernatants from (B) were assayed for
C5a+C3a by immunoblotting (std = 2ng).
(D) CFSE-labeled WT or C3/ H-2d Balb/c T cells
stimulated in vitro for 4 days with WT orC3/ BL/6
H-2b macrophages. Percent cells within gated
(C3/ versus WT cells, *p < 0.05). Each experi-
ment was repeated at least once with similar re-
sults. All error bars are ± SD.C3ar1/ mice survived for only 12 days, whereas all simulta-
neously infected WT mice appeared clinically healthy on day
12 (n = 5 per group) and survived for > 50 days (not shown).
Spleen cells from the WT animals sacrificed on both day 7 and
10 postinfection prior to appearing ill on day 12 responded
strongly to T. gondii antigens as assessed by IL-12 levels in
culture supernatants and a high frequency of antigen-specific
IFNg producers (Figure 3D, left). In contrast, at both time points,
spleen cells from the infected C5ar1/C3ar1/ mice contained
70% fewer IFNg-producing cells (p < 0.05) together with a
complete lack of IL-12 secretion (Figure 3D, right). In the T cell-
dependent MOG35–55-induced experimental autoimmune en-
cephalomyelitis (EAE) model of multiple sclerosis, WTs showed
characteristic weakness (clinical score >1.5), whereas C5ar1/
C3ar1/ mice showed less weakness (clinical score 0.5) that
persisted over time (n = 4 per group, p < 0.05). In a herpes kera-
titis model, in which inflammation is due to host T cell responses
against virally infected corneal cells rather than the virus itself,
corneas of WT mice completely opacified at day 14, whereas
corneas of C5ar1/C3ar1/ mice showed little or no change
(n = 5, p < 0.005; Figure 3F). Thus in all systems, both in vitro
and in vivo, T cell immunity in the absence of C5aR or C3aR on
APCs or T cells was markedly impaired.
C5a-C5aR+C3a-C3aR Engagements Function
as Autocrine Regulators
The finding that complement upregulation was maintained for
prolonged periods upon initial antigen stimulation (Figure 1) sug-
gested the possibility of an autocrine feedback loop in which
cognate interactions induce complement production and initiateactivation and locally produced C3a and C5a maintain upregu-
lated production of these components in both partners by virtue
of signaling through their C5aR+C3aR. Consistent with this,
blockade of C3aR+C5aR signaling with the specific antagonists
not only prevented OT-II T cell proliferation and cytokine secre-
tion (Figure 2) but also prevented the induced upregulation of
complement components and receptors in both partners (Fig-
ure 4A). Moreover, anti-CD3+anti-CD28 stimulation of OT-II cells
induced complement-component-gene upregulation in WT T
cells (Figure 4B), but the same treatment in the presence of the
C3aR-A and C5aR-A or upon stimulation of C5ar1/C3ar1/
T cells had no effect (Figure 4B). Immunoblots of culture super-
natants of anti-CD3+anti-CD28-stimulated OT-II cells showed
both C5a and C3a (Figure 4C), but >90% reduced C5a+C3a gen-
eration after 2 hr of incubation with C5aR-A and C3aR-A. Over-
exposures of unstimulated T cells in medium alone showed low-
level C5a and C3a production (lane 1), an intriguing result that will
be addressed below (see Figure 7). Analogously, APCs deficient
in both C3aR and C5aR did not upregulate gene expression for
complement components during cognate interactions with
TCR tg T cells (Figure S3). The C5ar1/C3ar1/ DCs showed
no differences from WTs in cell numbers or viability (not shown).
To further assess autocrine effects of C5a-C5aR+C3a-C3aR,
we evaluated T cell responses in a system in which either the
T cell or the APC, or both, were C5aR+C3aR disabled. As
shown in Figure 2D, the generation of IFNg-producing cells
was reduced to 20% when C5ar1/C3ar1/ DCs were used,
whereas it was reduced to <5% if the C5aR-A and C3aR-A or
anti-C5a/anti-C3a mAbs were added to block C5aR+C3aR
signals in the OT-II cells. Similarly, the WT Balb/c T cellImmunity 28, 425–435, March 2008 ª2008 Elsevier Inc. 429
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Local C5a+C3a Support T Cell Activation and SurvivalFigure 5. Locally Produced C5a and C3a
Influence APC-T Cell Interactions through
Regulating Costimulatory-Molecule Ex-
pression Levels
(A) Peritoneal macrophages and CD4+ T cells from
naive WT, C3/, C3ar1/, and C5ar1/ mice
were assayed for B7.1, B7.2, CD40, or CD28,
and anti-CD3+anti-CD28-stimulated CD4+ T cells
were assayed for CD40L expression levels by
flow cytometry. (I-Ab surface expression was
also decreased [not shown].)
(B) WT T cells and DCs were incubated for 1 hr at
37C with 100 ng/ml C5aR-A or C3aR-A, and cos-
timulatory molecule or MHC class II expression
was assayed by flow cytometry.
(C) The left side shows that CFSE-labeled Mar T
cells were incubated with WT or Cd80/Cd86/
DC and 1 mg/ml Dby peptide ± 100 ng/ml of C5a,
and proliferation was assessed by CFSE dilution.
In a second experiment (middle), the percentage
of cells undergoing greater than one or greater
than two divisions was quantified. The right side
shows that OT-II T cells were incubated for 18 hr
with Cd80/Cd86/ or CD40/ DCs ± 300 ng/
ml C5a, and IFNg+ T cells were quantitated by
ELISPOT (representative of two experiments; WT
versus Cd80/Cd86/, p < 0.05). C5a was
added once at time 0 rather than continuously as
occurs with CD28 signaling.
(D) WT,C3ar1/,C5ar1/, andC5ar1/C3ar1/
T cells were incubated in complete RPMI with
anti-CD3 (left), anti-CD3+anti-CD28 (middle), or
anti-CD3 + 300 ng/ml C5a (right) and IFNg+ cells
assayed at 48 hr by ELISPOT (n = 5 each group;
some dots overlap).
(E) WT, C3ar1/, or C5ar1/ T cells were incu-
bated with buffer, anti-CD3+anti-CD28, or anti-
CD3 + 300 ng/ml C5a and complement (C3)
mRNA transcripts measured by qPCR (represen-
tative of three experiments).
(F) The left side shows that WT, C3ar1/, or
C5ar1/ DCs were incubated for 4 hr ± 300 ng/
ml C5a, and Cd80 as well as Cd86 expression
was measured by flow cytometry. Similar results
were obtained in assays for I-Ab, CD40, with
both DCs and macrophages and for CD40L and
CD28 with T cells (data not shown). The right
side shows that WT or C3/Hc/ T cells were incubated with buffer, C5a, or anti-C3a+anti-C5a mAbs, and CD28 was measured as above.
(G) Base pairs 991 to +72 of the human B7.1 promoter were inserted into a luciferase reporter vector GL4 and transfected into THP-1 cells by electroporation.
After overnight incubation in complete medium, the cells were treated with 300 nM of C5a for 2 hr in serum-free media, and luciferase activity was measured with
a Lmax Luminometer (Molecular Devices). Each experiment was repeated at least once with similar results. *p < 0.05. All error bars are ± SD.proliferation in response to B6 C3/ APCs was reduced to
<50% of B6 WT APCs, and C3/ Balb/c T cell proliferation
was reduced to 10% in response to C3/ than WT APCs (Fig-
ure 4D), indicating that C3 production by the T cell as well as the
APC participates in proliferation. The findings, taken together
with those above, indicate that C3, fB, fD, and C5 produced
by either partner during cognate interactions can activate (i.e.,
generate C3a and C5a) and in turn function in both a paracrine
and autocrine manner to perpetuate local complement produc-
tion and drive T cell responses. In the absence of C5aR+C3aR
from either partner (in this serum-free in vitro system), no C5a or
C3a is produced, preventing T cell proliferation and differentia-
tion (Figure S4).430 Immunity 28, 425–435, March 2008 ª2008 Elsevier Inc.Disabling C5aR+C3aR Signaling Reduces
Costimulatory-Molecule Expression
To clarify how disabled C5aR+C3aR signaling diminishes T cell
responses, we examined costimulatory-molecule expression
patterns by flow cytometry (Figure 5A). These analyses showed
decreased surface expression of B7, CD40, and class II MHC
(not shown) on peritoneal macrophages from C5ar1/ and
C3ar1/ mice and essentially no staining on C5ar1/C3ar1/
DCs. Parallel analyses of C5aR-A- and C3aR-A-treated WT mac-
rophages showed similar reductions in costimulatory-molecule
expression (Figure 5B). Consistent with this, in the absence of
C3aR and C5aR on the APC, the cognate T cell APC interaction
failed to induce upregulation of IL-1, IL-23, and IL-12 (Figure S5).
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PI-3Kg, which in turn Promotes AKT
Phosphorylation
(A) The left side shows that WT T cells were acti-
vated with anti-CD3+anti-CD28, and at progres-
sively increasing times, buffer, C5aR-A, or C5aR-
A+C3aR-A were added; extracts were analyzed
for phospho-Ser473 AKT by Luminex assays (rep-
resentative of two experiments). (p < 0.05). The
right side shows that naive WT and C5ar1/
C3ar1/ T cells were incubated with 1 mg/ml of
anti-CD3+anti-CD28 at 37C and phospho-
Ser473 AKT assessed at increasing times.
(B) WT T cells were incubated at 37C with anti-
CD3+anti-CD28 (1 mg/ml each) for 3 min after
which the cells were incubated for 20 min with
buffer or 0.1 mM PI-3Kg-specific inhibitor PI-103.
Extracts were immunoblotted with anti-phospho-
Ser473 AKT or total AKT mAb (representative of
five experiments).
(C) OT-II T cells were incubated with 0.1 mM
OVA323–339, WT DCs, and 0.1 mM PI-103 ± 10 ng/
ml C5a. Complement, IL-2, and IFNg mRNAs
were quantitated by qPCR. All error bars are ± SD.We also examined CD28 and CD40L expression on WT and
C5ar1/C3ar1/ T cells by flow cytometry (Figure 5A). T cell
surface expression of CD28 was reduced by >90% on resting
C5ar1/C3ar1/ than on WT T cells, and CD40L levels were
similarly reduced after anti-CD3+anti-CD28 stimulation. Parallel
analyses of C5aR-A- and C3aR-A-treated WT T cells showed
similar reductions (Figure 5B).
Costimulatory-Molecule Expression Is Dependent
upon C5aR+C3aR Signaling
Costimulatory-molecule interactions are essential for optimal
APC induction of T cell responses (Lenschow et al., 1995).To es-
tablish whether locally produced C5a+C3a and upregulated ex-
pression of C5aR+C3aR (Figure 1) by APC-T cell partners and
costimulatory-molecule expression are mechanistically linked,
we tested whether abrogation of T cell responsiveness in the ab-
sence of costimulatory-molecule signaling can be reversed by
C3a+C5a addition. Consistent with this, diminished proliferation
of Mar CD4+ T cells (Dby plus I-Ab) in response to Cd80/
Cd86/ DCs was reversed upon addition of C5a (Figure 5C),
added C5a reconstituted diminished IFNg production by OT-II
cells stimulated with CD40/ APCs (Figure 5C), and addition
of anti-CD3 plus exogenous C5a led to a response equal that
of anti-CD3+anti-CD28 (Figure 5D). Consistent with the above
implicated autocrine loop (Figure 4), the exogenous C5a also
induced upregulation of local complement synthesis compara-
bly to that measured after anti-CD3+anti-CD28 stimulation and
greater than that detected after anti-CD3 stimulation alone (Fig-
ure 5E). Whereas C3ar1/ cells responded to exogenous C5a,
C5ar1/ T cells did not respond, demonstrating that the effects
are mediated through this receptor (as opposed to the alternative
C5a receptor, C5L2 [Cain and Monk, 2002]).
Strong support for a link between costimulation, T cell reactiv-
ity, local complement production, and C5aR+C3aR GPCR
signaling derives from the observation that diminished B7 and
CD28 expression on C3ar1/ (but not C5ar1/) DCs and
T cells, respectively (Figure 5A), was restored to WT values aftereither C5a or C3a addition (Figure 5F left). Likewise, C5a addition
to C3/Hc/ T cells restored CD28 expression whereas anti-
C5a+anti-C3a addition to WT T cells decreased CD28 expres-
sion (Figure 5F right). To directly confirm that both APC and
T cell costimulatory-molecule expression is controlled by C5aR
and C3aR GPCR signaling, we added human C5a to C5aR-
expressing THP1 cells transfected with a luciferase reporter
driven by the promoter of B7.1. The added C5a induced a lucifer-
ase signal indicative of C5aR dependent regulation (Figure 5G).
Overall, these data show that CD80, CD86 and CD40 costimula-
tion yield local complement production and subsequent genera-
tion of C5a+C3a. The resultant C5a and C3a fragments signal
through their GCPRs to upregulate costimulatory-molecule ex-
pression and directly drive T cell proliferation and differentiation.
C5a-C5aR+C3a-C3aR Signaling Is Linked to T Cell
Activation through PI3-Kg-Induced Phosphorylation
of AKT
Studies with Jurkat cells (Stein et al., 1994) have shown that
B7-CD28 ligation signals in T cells through phosphorylation of
Y170 residue in the YMNM motif in CD28’s cytoplasmic tail,
permitting SH2-dependent binding and activation of PI-3 kinase
p85ap110a (PI-3Ka). The activated PI-3Ka increases the amount
of internal leaflet-associated phosphatidylinositol 3,4,5 trisphos-
phate [PtdIns (3,4,5)P3], causing the recruitment of PDK1, PDK2,
and AKT via their pleckstrin homology (PH) domains [which en-
able them to bind PtdIns (3,4,5)P3]. This juxtaposition on PtdIns
(3,4,5)P3 allows PDK1+PDK2 to produce dually Thr
308Ser473
phosphorylated AKT that is centrally implicated in CD28 costimu-
latory signaling (Kane et al., 2001).
To test whether abrogated CD28 costimulation in the absence
or blockade of C5aR+C3aR (Figures 2 and 3) relates to a require-
ment for these GCPR signals for optimal AKT phosphorylation, we
stimulated WT T cells with anti-CD3+anti-CD28 ± C5aR-A and
C3aR-A and assessed AKT phosphorylation by immunoblotting
(Figure S6A) and Luminex assay (Figure 6A). Notably, whereas
addition of the C5aR-A diminished AKT phosphorylation, bothImmunity 28, 425–435, March 2008 ª2008 Elsevier Inc. 431
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tion and Signaling via the C5aR and C3aR
GPCRs Influences Cell Viability In Vitro and
In Vivo
(A) The left side shows that WT T cells were stained
with Alexa647-labeled Ab for detection of C3aR
and C5aR expression in resting T cells. The center
shows that WT T cells were incubated at 37C for
17 hr, supernatants were concentrated 10-fold,
and C3a or C5a were immunoblotted. The right
side shows that WT and C5ar1/C3ar1/ T cells
were incubated in complete RPMI 1640 and viabil-
ity assessed as described in the Experimental Pro-
cedures (representative of three experiments).
(B) WT and C5ar1/, C3ar1/, and C5ar1/
C3ar1/ T cells were incubated for 6 hr in se-
rum-free HL-1 medium and viability assayed.
(C) WT T cells were incubated at 37C for 6 hr in
HL-1 medium ± anti-C3a, anti-C5a, or anti-
C3a+anti-C5a and viability assessed.
(D) C3/ and C5-deficient T cells were incubated
for 6 hr in HL-1 medium ± 300 ng/ml C5a added at
time 0 and 90 min.
(E) Spleens from naive WT, C3ar1/, C5ar1/,
and C3ar1/C5ar1/ mice were isolated (three
to five animals per group), total cell numbers
were counted, and the CD3+ fraction was deter-
mined by flow cytometry (WT = 10%, C5ar1/ =
5.4%, C3ar1/ = 6.3, and C5ar1/C3ar1/ =
4.1%).
(F) Immediately after isolation and labeling, 106
CFSE–labeled WT T cells and CellTracker Red
CMTPX-labeled C5ar1/C3ar1/ T cells were
adoptively cotransferred into the same SCID mice (n = 4 mice per group for each time point). Surviving cells numbers were assayed at increasing times. Repeated
experiments switching the dyes gave the same results (data not shown). All experiments were performed at least twice with comparable results. *p < 0.05 WT
versus C5ar1/C3ar1/ cells. All error bars are ± SD.antagonists together virtually abolished it. Moreover, significantly
less phosphorylated AKT was detectable upon anti-CD3+anti-
CD28 stimulation of C5ar1/C3ar1/ T cells at all time points
tested (Figure 6B).
AKT is one product resulting from the activity of the p110 cat-
alytic subunit of PI-3 kinase p101gp110g (PI-3Kg), and PI-3Kg
has been tied to GCPR signal transduction in neutrophils and
macrophages (Sasaki et al., 2000). To test whether this signaling
pathway is operational in T cells, we incubated WT T cells with
anti-CD3+anti-CD28 plus a specific inhibitor (PI-103) (Kung
et al., 2006) of PI-3Kg. Strikingly, addition of the inhibitor (1) ab-
rogated anti-CD3+anti-CD28-induced phosphorylation of AKT
(Figure 6B), (2) prevented the upregulation of complement-
gene expression, and (3) eliminated upregulation of IL-2 and
IFNg mRNA expression (Figure 6C). Consistent with PI-3Kg
activation being mediated through C5aR ligation, these suppres-
sive effects could not be overcome by added C5a (Figure 6C).
Thus, C5aR- and C3aR-induced PI-3Kg activation is necessary
for AKT phosphorylation and resultant T cell activation.
C5aR+C3aR Signaling Is Essential for Sustaining
Naive T Cell Viability
In our experiments examining whether C5a-C5aR+C3a-C3aR
interactions in T cells operate in an autocrine fashion, on overex-
posed blots (not shown) we detected low levels of C5a+C3a in
culture supernatants in the absence of stimulation (Figure 4B),432 Immunity 28, 425–435, March 2008 ª2008 Elsevier Inc.a result raising the possibility that C5a+C3a is generated consti-
tutively and is important for T cell function. Moreover, we ob-
served reduced S473 AKT phosphorylation at early time points af-
ter preincubation of mouse T cells with the C5aR-A and C3aR-A
(Figure 6A and Figure S6A), further implicating C5a-C5aR+C3a-
C3aR interactions as operating tonically in naive T cells. The two
results would be consistent with preexisting C5a+C3a feeding
back on C5aR+C3aR to trigger ongoing basal GPCR activation.
In support of this, C5aR and C3aR could be detected on unsti-
mulated T cells with an ultrabright chromophore, WT but not
C5ar1/C3ar1/ T cells produced C5a and C3a at rest (Fig-
ure 7A), and as noted in Figure 6A, basal phospho S473 AKT
was readily detectable in WT T cells but was markedly reduced
in C5ar1/C3ar1/ T cells (Figure 6B). Because of the known
association of loss of phospho S473 AKT with induction of pro-
grammed cell death (PCD [Goruppi et al., 1997]), this connection
of disabled C5aR+C3aR GPCR signaling in naive unstimulated
cells with reduced phospho S473 AKT suggested the intriguing
possibility that in naive T cells, constitutive C5a-C5aR+C3a-
C3aR interactions play a role in maintaining viability.
To test this possibility, we compared the survival of WT and
C5ar1/C3ar1/ T cells in vitro after 48 hr of incubation in
10% heat-inactivated FCS. These analyses showed that in con-
trast to 5% loss of WT T cells, 20%–30% loss of C5ar1/
C3ar1/ T cells occurred (Figure 7A). To eliminate effects of
exogenous complement, growth factors, and other agents in
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dium. Fewer surviving C5ar1/C3ar1/ T cells were detected
at 6 hr, confirming that disrupted autocrine signaling through
both the C5aR and C3aR contributed to the decline (Figure 7B).
To confirm that these effects were not reflective of other pro-
cesses, we incubated naive WT T cells in serum-free medium
containing anti-C3a and/or anti-C5a mAbs against the C5aR+
C3aR ligands rather than blocking the receptors themselves
(Figure 7C). This caused a diminution in cell numbers similar to
that observed with C5ar1/C3ar1/ cells. As yet another test,
we added C5a to C5-deficient or C3/ T cells. This augmented
6 hr viability of both knockouts by 25%, close to the viability of
WT cells (Figure 7D). Thus, tonic C5a-C5aR+C3a-C3aR signal
transduction is necessary for maintaining T cells in a viable state.
The In Vivo Half-Lives of Naive T Cells Are Shorter
in the Absence of C5aR+C3aR Signaling
To document that the relationship between C5a-C5aR+C3a-
C3aR interactions and viability is relevant physiologically, we
compared the number of CD3+ T cells in spleens of naive
C5ar1/, C3ar1/, and C5ar1/C3ar1/ mice to those in
spleens of WT mice. The cell counts revealed 2-, 2-, and 3-fold
fewer C5ar1/, C3ar1/, and C5ar1/C3ar1/ T cells, re-
spectively, than WT CD3+ T cells per spleen (Figure 7E). Because
total cell number at steady state is a reflection of production and
destruction, we performed the more direct test of in vivo cell
survival. We coadoptively transferred equal numbers of naive
CellTracker Red CMTPX-labeled C5ar1/C3ar1/ and CFSE-
labeled WT T cells together into SCID mice and determined the
number of viable cells in spleens after the transfer (Figure 7F).
Similar numbers of each T cell population were detectable 8–
24 hr, indicating that the cells equally migrated to spleens after
the injection. However, significantly fewer C5ar1/C3ar1/
T cells were detectable in the recipient spleens on days 2–5,
consistent with the conclusion that viability is reduced. Control
studies in which the cell-membrane labels were switched yielded
the same results (data not shown). These studies thus docu-
ments that tonic C5a-C5aR and C3a-C3aR signal transduction
functions in vivo to maintain the viability of naive T cells.
DISCUSSION
The data in this study provide several important insights. First,
complement that is locally produced by APCs and T cells during
cognate interactions is integrally involved in the T cell activation
process. Specifically, C5a and C3a generated from this endoge-
nous production interact with C5aR and C3aR on both APCs and
T cells, and these engagements participate in activation and
cytokine production by both partners. Previous studies have re-
garded complement as being separate from T cells and APCs, at-
tributing complement’s effects on either cell coming from serum
complement rather than from the interacting APCs and T cells
themselves, i.e., from the outside-in rather than from the inside
of APCs and T cells themselves. Second, this study surprisingly
shows that in the naive state, T cells synthesize complement
components constitutively, and the resultant C5a and C3a sig-
naling through the C5aR and C3aR GPCRs participates in main-
taining their viability. If this process is interrupted, the generation
of phosphorylated AKT (PKB), a T cell activation intermediate thatsuppresses apoptosis, is reduced. That such a process operates
in naive T cells has not previously been recognized.
That the absence or blockade of C5aR+C3aR leads to lower
class II MHC and costimulatory-molecule expression is consis-
tent with previous work showing that MHC class II expression
is diminished on C3 deficient APCs (Peng et al., 2006). This
documented C5a-C5aR+C3a-C3aR regulation of class II and
costimulatory-molecule expression supports the conclusion
that one mechanism through which this GPCR signaling influ-
ences T cell responsiveness is through regulating antigen
presentation and B7-CD28 and CD40-CD40L costimulation.
How it affects other APC-T cell costimulatory-molecule expres-
sion and signaling or T cell development remains to be deter-
mined.
Our data demonstrate that C5aR and C3aR exhibit overlap-
ping but not fully redundant functions because inhibition or defi-
ciency of both has a significantly more profound effect than the
absence or blockade of either alone. These experimental results
in conjunction with the recent description of C3 bypass path-
ways for C5 cleavage (Huber-Lang et al., 2006; Kang et al.,
2006) explain why T cell immunity is diminished but not as fully
abrogated in the absence of C3, C5, C3aR, or C5aR individually.
The findings in this study establish that C5a-C5aR+C3a-C3aR
interactions function via both CD28 activation-dependent and -
independent mechanisms. CD28 dependence is supported by
the observation that CD28 and CD40L engagements upregulate
complement and downregulate DAF and that C5a can compen-
sate for CD28 and CD40L blockade or absence. They are consis-
tent with C5a acting both to upregulate costimulatory molecules
and to substitute for C5aR+C3aR signaling induced by B7 and
CD40 ligation of T cell CD28 and CD40L. APC deficiency of
C3, C5aR, and C3aR (each of which leads to less C5a+C3a)
markedly limits T cell proliferation and differentiation both in vitro
and in vivo. That these GPCR interactions additionally function
independently of CD28 is shown by the findings that they are
needed to maintain sufficient AKT phosphorylation to support
T cell survival: Naive T cells constitutively generate C5a and
C3a, C5ar1/C3ar1/ double-deficient cells exhibit reduced
viability in vitro and in vivo, addition of C5aR-A+C3aR-A or
anti-C5a+anti-C3a mAbs reduces viability of WT T cells, and
added C5a promotes viability ofHc/ andC3/ T cells. Studies
with bone-marrow chimeras (P.N.L., M.G.S., Min Yang, Feng Lin,
M.E.M., and P.S.H., unpublished data) showing that the absence
of C5aR from bone-marrow-derived cells but not parenchymal
cells limits responses of T cells in chimeric hosts support the
interpretation that C5a+C3a endogenously produced by APC-T
cell partners underlies each of the above results.
That deficient C5aR+C3aR expression suppresses IL-2 and
IFNg generation establishes an important role of amplified and
sustained C5aR+C3aR GPCR signaling in the initial costimula-
tory pathways of T cells. That disabled C5aR+C3aR GPCR
signaling in APCs suppresses IL-1, IL-12p35, and IL-23p19 pro-
duction also centrally implicates this signaling in elaboration of
these ‘‘Signal 3’’ cytokines. The findings regarding local APC-T
cell C5a-C5aR+C3a-C3aR interactions thus identify previously
uncovered GPCR steps that participate in both the in both
T cell and APC cytokine signaling pathways. They additionally
identify an unrecognized process that operates in naive T cells
to maintain their viability. Models of initial T cell costimulation
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loop are depicted in Figures S7A and S7B.
The linkage of bidirectional C5a+C3a signaling with B7-CD28
and CD40-CD40L costimulation during cognate APC-T cell inter-
actions provides a mechanistic basis for many previously unex-
plained observations concerning effects of complement-gene
deletions or added activation fragments on APC or T cell cytokine
production. Importantly, it explains why signaling via ‘‘unidenti-
fied GCPR(s)’’ has repeatedly been postulated to be involved
and PI-3Kg activation in T cell activation has been implicated (Al-
cazar et al., 2007; Deane and Fruman, 2004). The findings thus
have mechanistic as well as clinical relevance to adaptive immu-
nity and disease processes that are T cell mediated. Beyond this,
they highlight an unrecognized insight that complement func-
tions endogenously in T cells to maintain viability.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
Murine C5a was from Cell Sciences (Canton, ME). Mouse C3a and C5a mAbs
were from R&D Systems (Minneapolis, MN). Mouse IL-4, GM-CSF, and M-CSF
were from Peprotech (Rockyhill, NJ). Antibodies against mouse B7-1 and B7-2
were from BD PharMingen (San Diego, CA). Anti-CD40L mAb was from Bio
Express (West Lebanon, NH). Anti-C5aR and anti-C3aR were purchased
from Santa Cruz Biotech (Santa Cruz, CA). The PI-3K inhibitors were provided
by Dr. Kevin Shokat. Peptides were synthesized by Research Genetics as
described (Heeger et al., 2005).
Animals
C57BL/6, OT-II (specific for OVA323–339 plus I-A
b), Cd80/Cd86/, C3/,
C5-deficient, and CD40/ mice were from Jackson labs (Bar Harbor, ME).
C3/ mice and C3ar1/ and C5ar1/ were gifts of Dr. Michael Carroll and
Dr. Craig Gerard (Harvard Medical School and Children’s Hospital, Boston,
MA). Marilyn (MAR) transgenic was a gift of Polly Matzinger, Ghost Lab, NIH.
We generated Hc/C3/ mice by crossing C5-deficient B10.2 mice with
C57BL/6 congenic C3/ mice. C5+/+C3+/+ littermates used as controls dis-
played comparable results to the studies with C57BL/6 mice as controls. All
studies were approved by the Case Western Reserve University Institutional
Animal Care and Use Center (IACUC).
RNA Purification, cDNA Synthesis, and qPCR
Cells were extracted for 5 min at 20C with Trizol (Invitrogen, Carlsbad, CA) ac-
cording to the manufacturer’s instructions. When C3aR and C5aR mRNAs
were analyzed, preparations were treated with DNase I (standard protocol)
for removal of genomic DNA. We synthesized cDNAs by incubating 20 ul of
mRNAs in Sprint PowerScript Single Shots (Clontech, Mountain View, CA). A
total of 10 ul of diluted cDNA were mixed with 2 ul of primer and 10 ul SYBR
green master mix (Applied Biosystems, Foster City, CA) and assayed in tripli-
cate on an ABI prism 7000 cycler. In all assays, fold increases are relative to
each basal level and standardized to Actin.
Murine DCs and T Cells
Bone-marrow cells were grown in RPMI 1640/10% FBS containing 10 ug/ml
IL-4 + 10 ug/ml GM-CSF. Fresh media with the same cytokines was added
on day 3, 10 ug/ml IL-4 and 5 ug/ml GM-CSF were added on day 5, and cells
were used on day 6. T cells harvested from spleens were purified with T cell
enrichment columns (R&D Systems).
Immunizations, ELISPOT Assays and CFSE Proliferation,
and Flow Cytometry
Mice were immunized s.c. with OVA323–339 peptide as described (Heeger et al.,
2005). ELSPOT and proliferation assays were performed as described (Heeger
et al., 2005). All antibodies were purchased from BD PharMingen (San Diego,
CA), and stained cells were analyzed on a Becton Dickinson LSR II.434 Immunity 28, 425–435, March 2008 ª2008 Elsevier Inc.Anti-CD3 and Anti-CD28 Stimulations
Cells were stimulated for 1 hr with 1 mg/ml anti-CD3 and/or anti-CD28 (BD
Biosciences) in serum-free RPMI 1640 for qPCR analyses and for 48 and
72 hr for IFNg ELISPOT assays.
Immunoprecipitations
Cells were washed twice with PBS and extracted on ice for 10 min with 1%
NP-40, 150 mM NaCl, 1 mM PMSF, 0.4 mM EDTA, and a protease-inhibitor
cocktail (Complete Mini, Roche, Mannheim, Germany). After centrifugation
of extracts for 10 min at 13,000 3 g, supernatants were incubated for 1 hr at
4C with appropriate antibody, after which Sepharose A beads were added
and the mixture incubated overnight at 4C. Centrifuged pellets were washed
53, SDS sample buffer was added, and boiled samples were loaded onto
SDS-PAGE gels.
Immunoblotting
All blots were performed by standard procedure as described (Lin et al., 2001)
with HRP-conjugated secondary antibody and an ECL enhancer (GE Health-
care, Buckinghamshire, UK).
Quantitation of Murine C3 mRNA
A cDNA library was made from a C57BL/6 liver. The C3 standard was amplified
with the qPCR primer for C3 via conventional PCR and diluted to 106 copies/
mL. A standard curve was created with 10-fold dilutions of the C3 standard and
assayed by qPCR as above alongside with the cDNA libraries from total RNA
isolated from the T cells and DCs. A standard curve was constructed from the
CT values of the C3 standard, and the copies/mL of the samples were deter-
mined. We used the amount of total RNA from each sample to determine
the amount of copies/cell.
Luminex Assay
Cells were stimulated for increasing times with 1 mg/ml anti-CD3+anti-CD28
mAbs. After stimulation, cells were assayed for pAKT and tAKT with Upstate’s
Beadlyte assay according to the manufacturer’s instructions (Upstate, NY). In
brief, cells were placed on ice immediately after incubation, centrifuged at 4C,
lysed in the buffer provided by the company, incubated with the capture beads
and then the detection beads, washed, and assayed on the Bioplex 2200 (Bio-
rad, Hercules, CA).
Luciferase Activity Assay
The base pairs +72 to 991 of the human B7.1 promoter were inserted into a
luciferase reporter vector (GL4) then transfected into THP-1 cells by electropo-
ration (6 3 106 cells in 200 ml OptiMEM at 250 V and 950 mF). Cells were incu-
bated overnight in RPMI 1640 and 10% FBS, after incubation at 37C for 2 hr
with 300 nM C5a in serum-free RPMI 1640; luciferase activity was measured
with a Lmax Luminometer (Molecular Devices).
In Vitro Cell Viability
Mouse T cells purified by EasySep magnetic bead cocktails (StemCell Tech-
nologies, British Columbia) were cultured in 96-well plates in serum-free HL-
1 media containing L-glutamine and penicillin+streptomycin for the indicated
times or were cultured in complete RPMI 1640 (5% FBS, L-glutamine, penn/
strep). In some experiments, live and dead cells were counted with trypan
blue (Invitrogen, Carlsbad, CA). In others, cells were stained with Cy5-anti-
CD4/CD8, FITC-anti-CD44, and propidium iodide, mixed with Flow-Check
Fluorsperes (Beckman Coulter, Miami, FL), and analyzed on a LSR II flow
cytometer. Samples were normalized to 1000 Flow Check bead events.
In Vivo Cell Viability
CD4+ T cells from WT mice were labeled with CFSE (Invitrogen), and C5ar1/
C3ar1/ mice were labeled CellTracker Red CMTPX (Invitrogen); afterward,
2 3 106 of each type was injected via tail vein into SCID mice. At various
time points, two mice from each group were sacrificed, and total spleen cells
were assayed for percentage of labeled cells by flow cytometry.
Toxoplasmosis Infections
WT or C5ar1/C3ar1/ mice were infected i.p. with 20 cysts of T. gondii
(ME49 strain; n = 5). The C5ar1/C3ar1/ mice and a parallel set of WT
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spleen cells were isolated, stimulated with toxoplasma gondii antigen for 48
hr, and tested for IL-12 production by ELISA or IFNg by ELISPOT.
Statistics
Statistical significance for all experimental data was determined by the
Student’s t test.
SUPPLEMENTAL DATA
Seven figures are available at http://www.immunity.com/cgi/content/full/28/3/
425/DC1/.
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